Antiviral Drug Resistance Market Trends, Opportunities & Competitive Landscape
Protease inhibitors are a leading drug-class segment in the Antiviral Drug Resistance Market, reflecting demand for treatments that address resistant viral infections. The report values this segment at USD 1.5 billion in 2024 and projects it to reach USD 3 billion by 2035. Nucleoside analogues are another important category, with applications across several viral pathogens. Integrase inhibitors...
0 Reacties 0 aandelen 32 Views